• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   2000-2009  
Title Created Date
Melatonin-estrogen interactions in breast cancer 01 January 2014
Rationale for the use of somatostatin analogs as antitumor agents 30 December 2013
Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells 29 December 2013
Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition 28 December 2013
Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation 25 December 2013
Growth hormone and colorectal carcinoma: localization of receptors 25 December 2013
Detection of the retinoic acid-regulated genes in a RTBM1 neuroblastoma cell line using cDNA microarray 16 December 2013
Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment 13 December 2013
Growth inhibitory effect of the somatostatin structural derivative (TT-232) on leukemia models 13 December 2013
Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium 13 December 2013
Display # 

Page 95 of 111

  • Start
  • Prev
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • Next
  • End

Search

Follow us...

Latest

  • Melatonin and its ubiquitous anticancer effects
  • Vitamin E deficiency impairs the somatostatinergic receptor-effector system and leads to phosphotyrosine phosphatase overactivation and cell death in the rat hippocampus
  • Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
  • Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
  • High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer
  • The impact of vitamin D on cancer: A mini review
  • Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy
  • Somatostatin and Somatostatin Receptors in Tumour Biology
  • Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer
  • Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
  • Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells
  • An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress
  • Vitamin D Status in Pediatric Oncology Patients in Lebanon: A Comparison With Non-oncology Controls in a Case-Control Study
  • Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
  • Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
  • Targeting Melatonin to Mitochondria Mitigates Castration-Resistant Prostate Cancer by Inducing Pyroptosis
  • Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions
  • Is Melatonin the "Next Vitamin D"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Bibliography
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • How effective is chemo therapy?
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Vademecum
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer